Fentanyl sublingual spray (Subsys)

An opioid agonist indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

Patients must remain on around-the-clock opioids when taking SUBSYS.

Leave a Reply

Your email address will not be published. Required fields are marked *